MétaCan
Menu
Back to cohort
Record W2133349572 · doi:10.1002/humu.22025

Ovarian cancer susceptibility alleles and risk of ovarian cancer in<i>BRCA1</i>and<i>BRCA2</i>mutation carriers

2012· article· en· W2133349572 on OpenAlexafffund
Susan J. Ramus, Antonis C. Antoniou, Karoline B. Kuchenbaecker, Penny Soucy, Jonathan Beesley, Xiaoqing Chen, Lesley McGuffog, Olga M. Sinilnikova, Sue Healey, Daniel Barrowdale, Andrew Lee, Mads Thomassen, Anne‐Marie Gerdes, Torben A. Kruse, Uffe Birk Jensen, Anne‐Bine Skytte, Maria A. Caligo, Annelie Liljegren, Annika Lindblom, Håkan Olsson, Ulf Kristoffersson, Marie Stenmark‐Askmalm, Beatrice Melin, Susan M. Domchek, Katherine L. Nathanson, Timothy R. Rebbeck, Anna Jakubowska, Jan Lubiński, Katarzyna Jaworska, Katarzyna Durda, Elżbieta Złowocka, Jacek Gronwald, Tomasz Huzarski, Tomasz Byrski, Cezary Cybulski, Aleksandra Tołoczko‐Grabarek, Ana Osório, Javier Benítez, M. Durán, María‐Isabel Tejada, U. Hamann, Matti A. Rookus, Flora E. van Leeuwen, Cora M. Aalfs, Hanne E.J. Meijers-Heijboer, Christi J. van Asperen, Kees E. P. van Roozendaal, J. Margriet Collée, Mieke Kriege, Rob B. van der Luijt, S. Peock, Steve D. Ellis, Radka Platte, Elena Fineberg, D. Gareth Evans, Fiona Lalloo, Chris Jacobs, Rosalind A. Eeles, Julian Adlard, Rosemarie Davidson, Diana Eccles, T Cole, Jackie Cook, J. Paterson, Fiona Douglas, Carole Brewer, Shirley Hodgson, Patrick J. Morrison, Lisa Walker, Mary Porteous, Harsh B. Pathak, Andrew K. Godwin, Dominique Stoppa-Lyonnet, Virginie Caux-Moncoutier, Antoine de Pauw, Marion Gauthier-Villars, Sylvie Mazoyer, Mélanie Léoné, Alain Calender, Christine Lasset, Valérie Bonadona, Agnès Hardouin, Pascaline Berthet, Yves-Jean Bignon, Nancy Uhrhammer, Laurence Faivre, Catherine Loustalot, Saundra S. Buys, Mary Daly, Alex Miron, Mary Beth Terry, Wendy K. Chung, Esther M. John, Melissa C. Southey, David Goldgar, Christian F. Singer, Muy-Kheng Tea, Georg Pfeiler, A. Fink-Retter, Thomas van Overeem Hansen, Bent Ejlertsen, Oskar T. Johannsson, Kenneth Offit, Tomas Kirchhoff, Mia M. Gaudet, Joseph Vijai, Mark E. Robson, Marion Piedmonte, Kelly‐Anne Phillips, Linda Van Le, James Hoffman, Amanda Ewart Toland, Marco Montagna, Silvia Tognazzo, Evgeny Imyanitov, Claudine Isaacs, Ramūnas Janavičius, Conxi Lázaro, Ignacio Blanco, Eva Tornero, Matilde Navarro, Kirsten B. Moysich, Beth Karlan, Jenny Gross, Edith Olah, Vaszko Tibor, Soo‐Hwang Teo, Patricia A. Ganz, Mary Beattie, Cecelia M. Dorfling, Elizabeth J. van Rensburg, Orland Dı́ez, Ava Kwong, Rita K. Schmutzler, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Nina Ditsch, Norbert Arnold, Simone Heidemann, Dieter Niederacher, Sabine Preisler‐Adams, D Gadzicki, Raymonda Varon‐Mateeva, Helmut Deißler, Andrea Gehrig, Christian Sutter, Karin Kast, Britta Fiebig, Dieter Schäfer, Trinidad Caldés, Miguel de la Hoya, Heli Nevanlinna, Kristiina Aittomäki, Marie Plante, Amanda B. Spurdle, Susan L. Neuhausen, Yuan Chun Ding, Xianshu Wang, Noralane Lindor, Zachary Fredericksen, V. Shane Pankratz, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Bernardo Bonanni, Loris Bernard, Riccardo Dolcetti, Laura Papi, Laura Ottini, Paolo Radice, Mark H. Greene, Irene L. Andrulis, Gord Glendon, Hilmi Özçelik, Paul D.P. Pharoah, Simon A. Gayther, Jacques Simard, Douglas F. Easton, Fergus J. Couch, Georgia Chenevix‐Trench

Bibliographic record

VenueHuman Mutation · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsCancer Care OntarioUniversity of TorontoLunenfeld-Tanenbaum Research InstituteMount Sinai HospitalUniversité LavalCentre hospitalier universitaire de Québec
FundersMedical Research CouncilCancer Center, University of KansasNational Institutes of HealthIstituto Oncologico VenetoFondazione Italiana per la Ricerca sul CancroCancer Council VictoriaDeutsche KrebshilfeSahlgrenska UniversitetssjukhusetUmeå UniversitetNational Cancer InstituteLandspítali HáskólasjúkrahúsIstituto Toscano TumoriHungarian Scientific Research FundCanadian Institutes of Health ResearchUniversity of California, Los AngelesCancerfondenLunds UniversitetZonMwNational Breast Cancer FoundationNational Institute for Health and Care ResearchLinköpings UniversitetCanadian Breast Cancer Research AllianceRoyal Marsden NHS Foundation TrustOvarian Cancer Research FundHuntsman Cancer InstituteDeutsches KrebsforschungszentrumHelsingin ja Uudenmaan SairaanhoitopiiriUniversity of California, San FranciscoMinistero della SaluteAkademiska SjukhusetCancer Care OntarioCancer Research UKBeckman Research Institute, City of HopeFox Chase Cancer CenterAlleanza Contro il CancroUppsala UniversitetMinistero dell’Istruzione, dell’Università e della RicercaMemorial Sloan-Kettering Cancer CenterInstituto de Salud Carlos IIIOhio State UniversityNational Health and Medical Research CouncilKansas Bioscience AuthorityUniversity of PennsylvaniaRussian Foundation for Basic ResearchGeorgetown UniversityBreast Cancer Research FoundationU.S. Department of Defense
KeywordsOvarian cancerBiologyOdds ratioSingle-nucleotide polymorphismBreast cancerHazard ratioOncologyAlleleInternal medicinePopulationGenome-wide association studyCancerGeneticsGynecologyGenotypeMedicineConfidence intervalGene

Abstract

fetched live from OpenAlex

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Four single-nucleotide polymorphisms (SNPs), rs10088218 (at 8q24), rs2665390 (at 3q25), rs717852 (at 2q31), and rs9303542 (at 17q21), were genotyped in 12,599 BRCA1 and 7,132 BRCA2 carriers, including 2,678 ovarian cancer cases. Associations were evaluated within a retrospective cohort approach. All four loci were associated with ovarian cancer risk in BRCA2 carriers; rs10088218 per-allele hazard ratio (HR) = 0.81 (95% CI: 0.67-0.98) P-trend = 0.033, rs2665390 HR = 1.48 (95% CI: 1.21-1.83) P-trend = 1.8 × 10(-4), rs717852 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.6 × 10(-4), rs9303542 HR = 1.16 (95% CI: 1.02-1.33) P-trend = 0.026. Two loci were associated with ovarian cancer risk in BRCA1 carriers; rs10088218 per-allele HR = 0.89 (95% CI: 0.81-0.99) P-trend = 0.029, rs2665390 HR = 1.25 (95% CI: 1.10-1.42) P-trend = 6.1 × 10(-4). The HR estimates for the remaining loci were consistent with odds ratio estimates for the general population. The identification of multiple loci modifying ovarian cancer risk may be useful for counseling women with BRCA1 and BRCA2 mutations regarding their risk of ovarian cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.236
Threshold uncertainty score0.778

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.014
GPT teacher head0.294
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations38
Published2012
Admission routes2
Has abstractyes

Explore more

Same venueHuman MutationSame topicBRCA gene mutations in cancerFrench-language works237,207